REGEMAT 3D Participates in REBORN Project General Assembly in Berlin

Berlin, Germany – January 17, 2025 – This week, Manuel Figueruela García, CEO of
REGEMAT 3D, is attending the General Assembly of the REBORN Project in Berlin, a key
meeting bringing together consortium partners for collaborative exchange and strategic
alignment.
The in-person gathering highlights the significant progress achieved by the project over
the past months and reinforces the importance of collective innovation in addressing the
challenges of personalized regenerative medicine.
REGEMAT 3D is proud to contribute its expertise in 3D bioprinting and biofabrication,
actively supporting the mission of REBORN to develop next-generation personalized
therapeutic solutions.
This milestone reflects our ongoing commitment to European research and to advancing
scientific collaboration for the benefit of patients and healthcare systems.
For more information on our involvement in international projects, visit www.regemat3d.com